China Medical System Holdings Limited
0867.HKFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
971
Cost of Revenue
266
Gross Profit
705
Gross Margin
72.6%
Operating Income
225
Operating Margin
23.2%
Net Income
211
Net Margin
21.7%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
300
EBITDA Margin
30.9%
2023
12/31/2023
Revenue
1,042
Cost of Revenue
252
Gross Profit
790
Gross Margin
75.8%
Operating Income
353
Operating Margin
33.9%
Net Income
312
Net Margin
30.0%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
380
EBITDA Margin
36.5%
2022
12/31/2022
Revenue
1,190
Cost of Revenue
275
Gross Profit
915
Gross Margin
76.9%
Operating Income
462
Operating Margin
38.8%
Net Income
424
Net Margin
35.6%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
489
EBITDA Margin
41.1%
2021
12/31/2021
Revenue
1,084
Cost of Revenue
272
Gross Profit
812
Gross Margin
74.9%
Operating Income
410
Operating Margin
37.8%
Net Income
392
Net Margin
36.2%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
482
EBITDA Margin
44.4%
2020
12/31/2020
Revenue
903
Cost of Revenue
236
Gross Profit
667
Gross Margin
73.9%
Operating Income
359
Operating Margin
39.8%
Net Income
329
Net Margin
36.4%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
397
EBITDA Margin
43.9%